UniSa - IRIS Institutional Research Information System

PICILLO, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.360
NA - Nord America 6.036
EU - Europa 2.334
SA - Sud America 720
OC - Oceania 70
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.569
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 12.117
US - Stati Uniti d'America 5.923
SG - Singapore 858
BR - Brasile 621
CN - Cina 613
IT - Italia 542
RU - Federazione Russa 462
UA - Ucraina 331
VN - Vietnam 264
DE - Germania 238
IE - Irlanda 226
KR - Corea 176
TR - Turchia 157
SE - Svezia 148
GB - Regno Unito 88
FI - Finlandia 74
EE - Estonia 69
CA - Canada 62
IN - India 49
AU - Australia 43
NL - Olanda 35
AR - Argentina 29
BD - Bangladesh 28
MX - Messico 27
NZ - Nuova Zelanda 25
AT - Austria 21
EC - Ecuador 20
CZ - Repubblica Ceca 19
FR - Francia 19
IQ - Iraq 17
JP - Giappone 16
ES - Italia 15
CO - Colombia 14
PL - Polonia 14
ID - Indonesia 11
VE - Venezuela 10
ZA - Sudafrica 10
PY - Paraguay 9
UZ - Uzbekistan 9
NP - Nepal 7
KE - Kenya 6
MA - Marocco 6
PK - Pakistan 6
UY - Uruguay 6
CL - Cile 5
IL - Israele 5
JM - Giamaica 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
BO - Bolivia 4
EU - Europa 4
PA - Panama 4
SA - Arabia Saudita 4
DO - Repubblica Dominicana 3
GT - Guatemala 3
LU - Lussemburgo 3
MD - Moldavia 3
OM - Oman 3
AL - Albania 2
BG - Bulgaria 2
BS - Bahamas 2
BW - Botswana 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
LT - Lituania 2
MK - Macedonia 2
NO - Norvegia 2
PE - Perù 2
RS - Serbia 2
RW - Ruanda 2
SO - Somalia 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
CI - Costa d'Avorio 1
CU - Cuba 1
CV - Capo Verde 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
GA - Gabon 1
GH - Ghana 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
Totale 23.556
Salva come PNG Salva come JPEG
Città #
Hong Kong 12.109
Ann Arbor 1.168
Princeton 612
Chandler 520
Wilmington 468
Dallas 462
Jacksonville 409
Singapore 334
Houston 291
Ashburn 241
Dublin 219
Woodbridge 180
Dong Ket 144
Izmir 143
Beijing 129
Moscow 124
Andover 117
Nanjing 109
Naples 96
Boardman 82
Pellezzano 76
Tallinn 69
Salerno 66
Norwalk 62
Munich 55
Los Angeles 54
Dearborn 46
Düsseldorf 46
Shenyang 44
Ho Chi Minh City 41
São Paulo 39
Fairfield 37
Redwood City 37
West Jordan 35
Mestre 34
The Dalles 33
Changsha 32
Nanchang 32
Seoul 28
Columbus 27
Hanoi 27
Hebei 27
Nuremberg 25
Pune 25
Rio de Janeiro 24
Rome 23
Jiaxing 22
Council Bluffs 21
Santa Clara 21
Belo Horizonte 20
San Francisco 19
Milan 18
Sydney 18
Amsterdam 17
New York 17
Montreal 16
Brasília 15
San Diego 15
Tianjin 15
Washington 15
Lecce 14
Auckland 13
Seattle 13
Stockholm 13
Turku 13
Boston 12
Brooklyn 12
Curitiba 12
Lappeenranta 12
Brno 11
Guangzhou 11
Tokyo 11
Guarulhos 10
Baghdad 9
Campinas 9
Porto Alegre 9
Warsaw 9
Cambridge 8
Manchester 8
Ottawa 8
Ribeirão Preto 8
Shanghai 8
Tashkent 8
Atlanta 7
Casoria 7
Chennai 7
Guayaquil 7
Melbourne 7
Toronto 7
Can Tho 6
Carapicuíba 6
Dhaka 6
Fort Worth 6
Fortaleza 6
Goiânia 6
Haiphong 6
Jinan 6
Kunming 6
Mexico City 6
Montevideo 6
Totale 19.599
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.156
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 959
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 921
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 909
Sex Differences in Parkinson’s Disease: From Bench to Bedside 621
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 537
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 514
Gender differences in microRNA expression in levodopa-naive PD patients 510
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 475
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 472
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 429
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 426
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 426
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 389
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 357
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 328
Establishing a Standard of Care for Deep Brain Stimulation Centers in Canada 324
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 308
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 303
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 285
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 279
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 276
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 273
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 255
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 234
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 197
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 190
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 178
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 171
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 171
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 157
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 141
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 139
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 138
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 133
Increased bilirubin levels in de novo Parkinson's disease 123
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 123
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 120
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 117
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 117
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 116
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 114
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 113
Quitting smoking: An early non-motor feature of Parkinson's disease? 109
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 109
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 109
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 108
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 108
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 107
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 104
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family 103
Gender and non motor fluctuations in Parkinson's disease: A prospective study 100
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 98
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 97
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 97
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 95
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 95
The relevance of gender in Parkinson's disease: a review 93
Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards 93
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 92
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Sep;132(Pt 9):2350-5. PMID: 19584099 91
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 90
Early MRI findings in acquired hepatocerebral degeneration. 89
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 89
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 88
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 87
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 86
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 86
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale 86
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 86
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 85
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 85
Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family 85
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 84
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 84
Uric acid relates to dopamine transporter availability in Parkinson's disease. 83
Non-motor correlates of smoking habits in de novo Parkinson's disease 82
Programming Deep Brain Stimulation for Tremor and Dystonia: The Toronto Western Hospital Algorithms 82
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 81
Impact of COVID-19 on neurological patients attending a botulinum toxin service 80
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 79
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 79
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 79
Deep Brain Stimulation Target Selection for Parkinson's Disease 78
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 77
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 77
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease 77
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 76
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 76
Patients with Parkinson?s disease and scans with (predominant) ipsilateral dopaminergic deficit 75
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 75
Evolution of mild cognitive impairment in Parkinson disease 74
Resting brain networks in patients with Parkinson's disease and freezing of gait 73
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 72
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 71
Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy 71
Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects 71
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 70
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 70
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 69
Totale 19.439
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021617 0 0 0 4 106 64 90 5 72 5 84 187
2021/2022956 11 3 6 12 11 4 18 34 132 117 138 470
2022/20231.387 183 95 70 109 180 309 16 125 189 9 72 30
2023/2024947 52 116 44 65 34 113 42 83 61 78 79 180
2024/20252.692 84 26 46 164 106 233 341 248 465 315 344 320
2025/202613.530 3.579 5.250 4.530 171 0 0 0 0 0 0 0 0
Totale 24.040